ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Grapefruit Juice on the Response to Clopidogrel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00817999
Recruitment Status : Completed
First Posted : January 7, 2009
Results First Posted : October 1, 2012
Last Update Posted : October 1, 2012
Sponsor:
Information provided by (Responsible Party):
Creighton University

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Crossover Assignment;   Masking: None (Open Label);   Primary Purpose: Screening
Condition Healthy
Interventions Dietary Supplement: Grapefruit juice
Drug: Clopidogrel 75 mg/day
Drug: Clopidogrel 300 mg
Enrollment 32
Recruitment Details  
Pre-assignment Details  
Arm/Group Title Loading Dose Maintenance Dose
Hide Arm/Group Description Healthy volunteers who received a 300 mg dose of clopidogrel with or without grapefruit juice. Healthy volunteers who received clopidogrel 75 mg/day for 7 days during each period with or without grapefruit juice.
Period Title: Grapefruit Juice
Started 15 17
Completed 15 17
Not Completed 0 0
Period Title: No Grapefruit Juice
Started 15 17
Completed 15 17
Not Completed 0 0
Arm/Group Title Loading Dose Maintenance Dose Total
Hide Arm/Group Description [Not Specified] [Not Specified] Total of all reporting groups
Overall Number of Baseline Participants 15 17 32
Hide Baseline Analysis Population Description
[Not Specified]
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 15 participants 17 participants 32 participants
<=18 years
0
   0.0%
0
   0.0%
0
   0.0%
Between 18 and 65 years
15
 100.0%
17
 100.0%
32
 100.0%
>=65 years
0
   0.0%
0
   0.0%
0
   0.0%
Age Continuous  
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 15 participants 17 participants 32 participants
24.4  (5.9) 25.47  (5.66) 25.47  (5.66)
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 15 participants 17 participants 32 participants
Female
10
  66.7%
13
  76.5%
23
  71.9%
Male
5
  33.3%
4
  23.5%
9
  28.1%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 15 participants 17 participants 32 participants
15 17 32
1.Primary Outcome
Title % Platelet Inhibition
Hide Description % platelet inhibition measured by Verify Now
Time Frame 6 hours
Show Outcome Measure DataHide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Loading Dose With Grapefruit Juice Maintenance Dose With Grapefruit Juice Loading Dose Without Grapefruit Juice Maintenance Dose Without Grapefruit Juice
Hide Arm/Group Description:
[Not Specified]
[Not Specified]
[Not Specified]
[Not Specified]
Overall Number of Participants Analyzed 15 17 15 17
Mean (Standard Deviation)
Unit of Measure: percentage of platelet inhibition
23.4  (14.2) 24.6  (24.2) 41.2  (19.1) 59  (22.5)
Time Frame [Not Specified]
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title Loading Dose Maintenance Dose
Hide Arm/Group Description [Not Specified] [Not Specified]
All-Cause Mortality
Loading Dose Maintenance Dose
Affected / at Risk (%) Affected / at Risk (%)
Total   --/--   --/-- 
Show Serious Adverse Events Hide Serious Adverse Events
Loading Dose Maintenance Dose
Affected / at Risk (%) Affected / at Risk (%)
Total   0/15 (0.00%)   0/17 (0.00%) 
Show Other (Not Including Serious) Adverse Events Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 5%
Loading Dose Maintenance Dose
Affected / at Risk (%) Affected / at Risk (%)
Total   0/15 (0.00%)   0/17 (0.00%) 
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
Results Point of Contact
Name/Title: Tammy Burns, PharmD
Organization: Creighton University
Phone: 402-280-4292
Responsible Party: Creighton University
ClinicalTrials.gov Identifier: NCT00817999     History of Changes
Other Study ID Numbers: 08-15073
First Submitted: January 6, 2009
First Posted: January 7, 2009
Results First Submitted: August 8, 2011
Results First Posted: October 1, 2012
Last Update Posted: October 1, 2012